Bacteria in the gut have been implicated in autoimmune diseases, like lupus, that don't primarily affect the gastrointestinal ...
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
Hosted on MSN1mon
Neoself-antigens found to induce autoimmune response in lupusThe paper is titled "Neoself-antigens are the primary target for autoreactive T cells in human lupus." Autoimmune diseases develop when the body's immune system mistakenly attacks its own tissues ...
Your gut microbiome can trigger an immune response, leading to chronic systemic inflammation and lupus. Here are some tips to ...
Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...
Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...
The study examines 79 lupus patients and 64 healthy individuals, focusing on B cells, the antibody-producing white blood cells vital for immune defense. In healthy individuals, mRNA COVID-19 ...
The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...
Unlike CAR-T cells, NK cells don’t need genetic modification to recognize a specific threat — they act broadly without ...
The researchers believe their findings will have broad application to autoimmune diseases with defective B cell components beyond just lupus, while providing more insights into personalized ...
Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback